Testing effectiveness (Phase 2)Ended earlyNCT04067492
What this trial is testing
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
Who this might be right for
Gout Attack
R-Pharm 47